Insider Trading & Ownership - Cui Xiangmin

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Cui Xiangmin
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-06-25
Purchase
2024-06-26
4:31 pm
Nuvation Bio Inc.NUVBCui Xiangmin
Director
277,895$2.97$825,3486,950,239
(Indirect)
View
2024-06-20
Purchase
2024-06-25
5:45 pm
Nuvation Bio Inc.NUVBCui Xiangmin
Director
500,000$2.9848$1,492,3856,672,344
(Indirect)
View
2024-01-29
Purchase(A)
2024-04-09
7:08 pm
CG Oncology Inc.CGONDecheng Capital Global Life Sciences Fund IV L.P.
Decheng Capital Management IV (Cayman) LLC
Decheng Capital Global Healthcare Fund (Master) LP
Decheng Capital Global Healthcare GP LLC
Cui Xiangmin
10% Owner
400,000$19$7,600,0004,958,810
(Direct)
View
2024-01-29
Purchase
2024-01-31
4:17 pm
CG Oncology Inc.CGONDecheng Capital Global Life Sciences Fund IV L.P.
Decheng Capital Management IV (Cayman) LLC
Decheng Capital Global Healthcare Fund (Master) LP
Decheng Capital Global Healthcare GP LLC
Cui Xiangmin
10% Owner
400,000$19$7,600,0004,958,812
(Indirect
Direct)
View
2023-11-09
Purchase
2023-11-14
5:33 pm
ALPINE IMMUNE SCIENCES INC.ALPNCui Xiangmin
Director
10% Owner
375,000$12.5$4,687,5007,083,288
(Indirect)
View
2021-09-17
Purchase
2021-09-21
5:12 pm
ALPINE IMMUNE SCIENCES INC.ALPNCui Xiangmin
Director
10% Owner
1,542,553$9.4$14,499,9984,708,288
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-09-04
Conversion
2024-09-05
4:15 pm
N/A
N/A
Nuvation Bio Inc.NUVBCui Xiangmin
Director
19,194,242$017,898,301
(Indirect)
View
2024-09-03
Option Award
2024-09-05
4:15 pm
N/A
N/A
Nuvation Bio Inc.NUVBCui Xiangmin
Director
836,099$017,898,301
(Indirect)
View
2024-05-20
Disposition
2024-05-20
8:08 pm
N/A
2029-01-17
ALPINE IMMUNE SCIENCES INC.ALPNCui Xiangmin
Decheng Capital China Life Sciences USD Fund III L.P.
Decheng Capital Management III (Cayman) LLC
Decheng Capital Global Healthcare Fund (Master) LP
Decheng Capital Global Healthcare GP LLC
Director
10% Owner
60,450$00
(Direct)
View
2024-05-18
Equity Swap
2024-05-20
8:08 pm
N/A
N/A
ALPINE IMMUNE SCIENCES INC.ALPNCui Xiangmin
Decheng Capital China Life Sciences USD Fund III L.P.
Decheng Capital Management III (Cayman) LLC
Decheng Capital Global Healthcare Fund (Master) LP
Decheng Capital Global Healthcare GP LLC
Director
10% Owner
8,317,924$00
(Indirect)
View
2024-04-09
Option Award
2024-04-11
9:01 pm
N/A
N/A
Nuvation Bio Inc.NUVBCui Xiangmin
Director
6,172,344$04,183,002
(Indirect)
View
2024-01-29
Conversion
2024-01-31
4:17 pm
N/A
N/A
CG Oncology Inc.CGONDecheng Capital Global Life Sciences Fund IV L.P.
Decheng Capital Management IV (Cayman) LLC
Decheng Capital Global Healthcare Fund (Master) LP
Decheng Capital Global Healthcare GP LLC
Cui Xiangmin
10% Owner
38,223,094$04,958,812
(Direct)
View

Ownership
2024-01-24
8:26 pm
N/A
N/A
CG Oncology Inc.CGONDecheng Capital Global Life Sciences Fund IV L.P.
Decheng Capital Management IV (Cayman) LLC
Cui Xiangmin
10% Owner
0$04,558,810
(Direct)
View
2024-01-18
Exercise
2024-01-22
5:48 pm
2019-01-18
2024-01-18
ALPINE IMMUNE SCIENCES INC.ALPNCui Xiangmin
Director
10% Owner
1,234,636$08,317,924
(Indirect)
View
2024-01-18
Exercise
2024-01-22
5:48 pm
N/A
N/A
ALPINE IMMUNE SCIENCES INC.ALPNCui Xiangmin
Director
10% Owner
1,234,636$12.748,317,924
(Indirect)
View
2024-01-02
Option Award
2024-01-04
7:03 pm
N/A
2034-01-01
ALPINE IMMUNE SCIENCES INC.ALPNCui Xiangmin
Director
10% Owner
17,500$017,500
(Direct)
View
2023-01-03
Option Award
2023-01-05
6:55 pm
N/A
2033-01-02
ALPINE IMMUNE SCIENCES INC.ALPNCui Xiangmin
Director
10% Owner
10,000$010,000
(Direct)
View
2022-09-23
Option Award
2022-09-27
4:51 pm
N/A
N/A
ALPINE IMMUNE SCIENCES INC.ALPNCui Xiangmin
Director
10% Owner
2,000,000$7.351,360,544
(Indirect)
View
2022-01-03
Option Award
2022-01-04
5:17 pm
N/A
2032-01-02
ALPINE IMMUNE SCIENCES INC.ALPNCui Xiangmin
Director
10% Owner
10,000$010,000
(Direct)
View
2021-09-28
Conversion
2021-09-30
5:43 pm
N/A
N/A
Cue Health Inc.HLTHCui Xiangmin
Director
8,192,468$0788,441
(Indirect)
View
2021-09-28
Option Award
2021-09-30
5:43 pm
N/A
N/A
Cue Health Inc.HLTHCui Xiangmin
Director
788,441$12.8788,441
(Indirect)
View

Ownership
2021-09-23
9:06 pm
N/A
N/A
Cue Health Inc.HLTHCui Xiangmin
Director
10% Owner
0$08,192,468
(Indirect)
View

Ownership
2021-09-23
9:06 pm
N/A
N/A
Cue Health Inc.HLTHDecheng Capital China Life Sciences USD Fund III L.P.
Decheng Capital Management III (Cayman) LLC
Cui Xiangmin
10% Owner
0$08,192,468
(Direct)
View

Ownership
2021-02-16
5:22 pm
N/A
N/A
Equillium Inc.EQDecheng Capital Global Life Sciences Fund IV L.P.
Decheng Capital Management IV (Cayman) LLC
Cui Xiangmin
10% Owner
0$04,271,423
(Indirect)
View
2021-01-04
Option Award
2021-01-05
7:06 pm
N/A
2031-01-03
ALPINE IMMUNE SCIENCES INC.ALPNCui Xiangmin
Director
10% Owner
7,650$07,650
(Direct)
View
2020-01-02
Option Award
2020-01-06
8:01 pm
N/A
2030-01-01
ALPINE IMMUNE SCIENCES INC.ALPNCui Xiangmin
Director
10% Owner
7,650$07,650
(Direct)
View
(A) Indicate amendment filing.